Conor McNamara
Stock Analyst at RBC Capital
(1.28)
# 3,648
Out of 5,042 analysts
141
Total ratings
34.95%
Success rate
-11.89%
Average return
Main Sectors:
Stocks Rated by Conor McNamara
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TECH Bio-Techne | Upgrades: Outperform | $61 → $73 | $65.91 | +10.77% | 11 | Sep 3, 2025 | |
| MRVI Maravai LifeSciences Holdings | Maintains: Outperform | $7 → $5 | $3.41 | +46.63% | 7 | Aug 12, 2025 | |
| NTRA Natera | Maintains: Outperform | $251 → $255 | $192.51 | +32.46% | 2 | Aug 8, 2025 | |
| OABI OmniAb | Maintains: Outperform | $4 → $3 | $1.63 | +84.05% | 4 | Aug 7, 2025 | |
| EXAS Exact Sciences | Maintains: Sector Perform | $54 → $46 | $64.64 | -28.84% | 1 | Aug 7, 2025 | |
| HOLX Hologic | Upgrades: Outperform | $72 → $87 | $73.99 | +17.58% | 12 | Aug 6, 2025 | |
| AVTR Avantor | Maintains: Outperform | $20 → $17 | $15.40 | +10.39% | 9 | Aug 4, 2025 | |
| ILMN Illumina | Maintains: Outperform | $118 → $126 | $100.11 | +25.86% | 16 | Aug 1, 2025 | |
| BIO Bio-Rad Laboratories | Maintains: Outperform | $387 → $409 | $339.75 | +20.38% | 14 | Aug 1, 2025 | |
| BIO.B Bio-Rad Laboratories | Maintains: Outperform | $387 → $409 | $343.83 | +18.95% | 14 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $193 → $204 | $166.33 | +22.65% | 12 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $651 → $637 | $572.50 | +11.27% | 14 | Apr 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $250 | $223.01 | +12.10% | 10 | Apr 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $64 → $61 | $30.51 | +99.93% | 11 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $8 → $7 | $4.25 | +64.71% | 4 | Aug 7, 2024 |
Bio-Techne
Sep 3, 2025
Upgrades: Outperform
Price Target: $61 → $73
Current: $65.91
Upside: +10.77%
Maravai LifeSciences Holdings
Aug 12, 2025
Maintains: Outperform
Price Target: $7 → $5
Current: $3.41
Upside: +46.63%
Natera
Aug 8, 2025
Maintains: Outperform
Price Target: $251 → $255
Current: $192.51
Upside: +32.46%
OmniAb
Aug 7, 2025
Maintains: Outperform
Price Target: $4 → $3
Current: $1.63
Upside: +84.05%
Exact Sciences
Aug 7, 2025
Maintains: Sector Perform
Price Target: $54 → $46
Current: $64.64
Upside: -28.84%
Hologic
Aug 6, 2025
Upgrades: Outperform
Price Target: $72 → $87
Current: $73.99
Upside: +17.58%
Avantor
Aug 4, 2025
Maintains: Outperform
Price Target: $20 → $17
Current: $15.40
Upside: +10.39%
Illumina
Aug 1, 2025
Maintains: Outperform
Price Target: $118 → $126
Current: $100.11
Upside: +25.86%
Bio-Rad Laboratories
Aug 1, 2025
Maintains: Outperform
Price Target: $387 → $409
Current: $339.75
Upside: +20.38%
Bio-Rad Laboratories
Aug 1, 2025
Maintains: Outperform
Price Target: $387 → $409
Current: $343.83
Upside: +18.95%
Jul 30, 2025
Maintains: Outperform
Price Target: $193 → $204
Current: $166.33
Upside: +22.65%
Apr 24, 2025
Maintains: Outperform
Price Target: $651 → $637
Current: $572.50
Upside: +11.27%
Apr 23, 2025
Reiterates: Outperform
Price Target: $250
Current: $223.01
Upside: +12.10%
Feb 13, 2025
Maintains: Outperform
Price Target: $64 → $61
Current: $30.51
Upside: +99.93%
Aug 7, 2024
Maintains: Outperform
Price Target: $8 → $7
Current: $4.25
Upside: +64.71%